Evidence map›Paper›PMID 33649198›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Human DNA methylation signatures differentiate persistent from resolving MRSA bacteremia.

Yu-Ling Chang, Maura Rossetti, David W Gjertson, Liudmilla Rubbi, Michael Thompson, Dennis J Montoya, Marco Morselli, Felicia Ruffin, Alexander Hoffmann, Matteo Pellegrini and 4 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Epigenetic mechanisms mediate cytochrome P450 1A1 expression and lung endothelial injury caused by MRSA in vitro and in vivo.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Persistent Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Article
  19. Frontiers in cellular and infection microbiology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Yu-Ling ChangDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.ORCID 0000-0002-0789-4989
Maura RossettiDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
David W GjertsonDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
Liudmilla RubbiDepartment of Molecular Cell and Developmental Biology, University of California, Los Angeles, CA 90095.
Michael ThompsonDepartment of Molecular Cell and Developmental Biology, University of California, Los Angeles, CA 90095.ORCID 0000-0002-2914-1080
Dennis J MontoyaSchool of Medicine, University of California, Davis, CA 95616.ORCID 0000-0002-0802-3309
Marco MorselliDepartment of Molecular Cell and Developmental Biology, University of California, Los Angeles, CA 90095.ORCID 0000-0003-3351-5791
Felicia RuffinDivision of Infectious Diseases, Duke University, Durham, NC 27710.
Alexander HoffmannInstitute for Quantitative and Computational Biosciences, University of California, Los Angeles, CA 90095.ORCID 0000-0002-5607-3845
Matteo PellegriniDepartment of Molecular Cell and Developmental Biology, University of California, Los Angeles, CA 90095.ORCID 0000-0001-9355-9564
Vance G FowlerDivision of Infectious Diseases, Duke University, Durham, NC 27710.ORCID 0000-0002-8048-0897
Michael R YeamanDivision of Molecular Medicine, Harbor-University of California, Los Angeles Medical Center, Torrance, CA 90502.
Elaine F ReedDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; EReed@mednet.ucla.edu.
with the MRSA Systems Immunology Group
University of California, Los Angeles · USDuke University · USQB3 · USUniversity of California, Davis · US

Funding

The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
Project 3: Mapping the Evolution of Chronic Transplant Injury in the Context of CMV InfectionU19AI128913 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REED, ELAINE F, SARWAL, MINNIE M · 2017 to 2021
$11.2M
Systems Immunolobiology of Antibiotic-Persistent MRSA InfectionU01AI124319 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2020
$10.1M
Host Susceptibility to S. aureusR01AI068804 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2007 to 2016
$6.9M
The role of purine biosynthesis and stringent response in persistent MRSA endovascular infectionsR01AI139244 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI XIONG, YAN Q. · 2019 to 2023
$2.2M
Mitigating Resistance & Virulence in MRSAR33AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2018
$1.2M
NCATS NIH HHS KL2 TR001882NIAID NIH HHS R01 AI068804NIAID NIH HHS R01 AI139244NIAID NIH HHS R33 AI111661NIAID NIH HHS U01 AI124319NIAID NIH HHS U19 AI128913
6 · The paper itself

Abstract

Persistent methicillin-resistant

Indexed as

DNA MethylationResponse ElementsAnti-Bacterial AgentsBacteremiaCCAAT-Enhancer-Binding Protein-betaFemaleHumansMaleMethicillin-Resistant Staphylococcus aureusMiddle Agedp300-CBP-Associated Factorp300-CBP Transcription FactorsStaphylococcal InfectionsSTAT1 Transcription FactorAnti-Bacterial AgentsCCAAT-Enhancer-Binding Protein-betaCEBPB protein, humanp300-CBP-Associated Factorp300-CBP Transcription FactorsSTAT1 protein, humanSTAT1 Transcription FactorDNA methylationepigeneticsMRSApersistenceStaphylococcus aureus

Identifiers

PMID33649198
PMCPMC7958259
OpenAlexW3134624841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.